title: Control of conformational equilibria in the human B2 bradykinin receptor. Modeling of nonpeptidic ligand action and comparison to the rhodopsin structure.
abstract: A prototypic study of the molecular mechanisms of activation or inactivation of peptide hormone G protein-coupled receptors was carried out on the human B2 bradykinin receptor. A detailed pharmacological analysis of receptor mutants possessing either increased constitutive activity or impaired activation or ligand recognition allowed us to propose key residues participating in intramolecular interaction networks stabilizing receptor inactive or active conformations: Asn(113) and Tyr(115) (TM III), Trp(256) and Phe(259) (TM VI), Tyr(295) (TM VII) which are homologous of the rhodopsin residues Gly(120), Glu(122), Trp(265), Tyr(268), and Lys(296), respectively. An essential experimental finding was the spatial proximity between Asn(113), which is the cornerstone of inactive conformations, and Trp(256) which plays a subtle role in controlling the balance between active and inactive conformations. Molecular modeling and mutagenesis data showed that Trp(256) and Tyr(295) constitute, together with Gln(288), receptor contact points with original nonpeptidic ligands. It provided an explanation for the ligand inverse agonist behavior on the WT receptor, with underlying restricted motions of TMs III, VI, and VII, and its agonist behavior on the Ala(113) and Phe(256) constitutively activated mutants. These data on the B2 receptor emphasize that conformational equilibria are controlled in a coordinated fashion by key residues which are located at strategic positions for several G protein-coupled receptors. They are discussed in comparison with the recently determined rhodopsin crystallographic structure.
authors.affiliation: INSERM U439, 70 rue de Navacelles 34090 Montpellier, France.
authors.forename: J
authors.initials: J
authors.lastname: Marie
authors.forename: E
authors.initials: E
authors.lastname: Richard
authors.forename: D
authors.initials: D
authors.lastname: Pruneau
authors.forename: J L
authors.initials: JL
authors.lastname: Paquet
authors.forename: C
authors.initials: C
authors.lastname: Siatka
authors.forename: R
authors.initials: R
authors.lastname: Larguier
authors.forename: C
authors.initials: C
authors.lastname: Poncé
authors.forename: P
authors.initials: P
authors.lastname: Vassault
authors.forename: T
authors.initials: T
authors.lastname: Groblewski
authors.forename: B
authors.initials: B
authors.lastname: Maigret
authors.forename: J C
authors.initials: JC
authors.lastname: Bonnafous
mesh_terms: D000595:Amino Acid Sequence; D001216:Asparagine / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D008024:Ligands; D008969:Molecular Sequence Data; D016297:Mutagenesis, Site-Directed; D011487:Protein Conformation; D043782:Receptor, Bradykinin B2; D018002:Receptors, Bradykinin / Q000737:chemistry* / Q000378:metabolism; D012243:Rhodopsin / Q000737:chemistry*; D017386:Sequence Homology, Amino Acid; D014364:Tryptophan / Q000737:chemistry / Q000378:metabolism
chemical_list: D008024:Ligands; D043782:Receptor, Bradykinin B2; D018002:Receptors, Bradykinin; D001216:Asparagine; D014364:Tryptophan; D012243:Rhodopsin